Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans

Traditional Chinese medicine (TCM) serves as a significant adjunct to chemical treatment for chronic diseases. For instance, the administration of Baitouweng decoction (BTWD) has proven effective in the treatment of ulcerative colitis. However, the limited understanding of its pharmacokinetics (PK)...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianqian Xu, Huilan Gao, Fuqiang Zhu, Wenliang Xu, Yubo Wang, Jinwen Xie, Guangjun Guo, Limei Yang, Li Ma, Zhiqiang Shen, Jichang Li
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:International Journal of Analytical Chemistry
Online Access:http://dx.doi.org/10.1155/2024/5535752
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553094640041984
author Qianqian Xu
Huilan Gao
Fuqiang Zhu
Wenliang Xu
Yubo Wang
Jinwen Xie
Guangjun Guo
Limei Yang
Li Ma
Zhiqiang Shen
Jichang Li
author_facet Qianqian Xu
Huilan Gao
Fuqiang Zhu
Wenliang Xu
Yubo Wang
Jinwen Xie
Guangjun Guo
Limei Yang
Li Ma
Zhiqiang Shen
Jichang Li
author_sort Qianqian Xu
collection DOAJ
description Traditional Chinese medicine (TCM) serves as a significant adjunct to chemical treatment for chronic diseases. For instance, the administration of Baitouweng decoction (BTWD) has proven effective in the treatment of ulcerative colitis. However, the limited understanding of its pharmacokinetics (PK) has impeded its widespread use. Chinese Bama miniature pigs possess anatomical and physiological similarities to the human body, making them a valuable model for investigating PK properties. Consequently, the identification of PK properties in Bama miniature pigs can provide valuable insights for guiding the clinical application of BTWD in humans. To facilitate this research, a rapid and sensitive UPLC-MS/MS method has been developed for the simultaneous quantification of eleven active ingredients of BTWD in plasma. Chromatographic separation was conducted using an Acquity UPLC HSS T3 C18 column and a gradient mobile phase comprising acetonitrile and water (containing 0.1% acetic acid). The methodology was validated in accordance with the FDA Bioanalytical Method Validation Guidance for Industry. The lower limit of quantitation fell within the range of 0.60–2.01 ng/mL. Pharmacokinetic studies indicated that coptisine chloride, berberine, columbamine, phellodendrine, and obacunone exhibited low Cmax, while fraxetin, esculin, fraxin, and pulchinenoside B4 were rapidly absorbed and eliminated from the plasma. These findings have implications for the development of effective components in BTWD and the adjustment of clinical dosage regimens.
format Article
id doaj-art-f6354920ee1a42219135576c37495560
institution Kabale University
issn 1687-8779
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series International Journal of Analytical Chemistry
spelling doaj-art-f6354920ee1a42219135576c374955602025-02-03T05:56:55ZengWileyInternational Journal of Analytical Chemistry1687-87792024-01-01202410.1155/2024/5535752Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in HumansQianqian Xu0Huilan Gao1Fuqiang Zhu2Wenliang Xu3Yubo Wang4Jinwen Xie5Guangjun Guo6Limei Yang7Li Ma8Zhiqiang Shen9Jichang Li10Shandong Binzhou Animal Science and Veterinary Medicine AcademyBinzhou Inspection and Testing CenterBinzhou Inspection and Testing CenterSchool of Food and Advanced TechnologyDepartment of Thoracic SurgeryShandong Binzhou Animal Science and Veterinary Medicine AcademyShandong Binzhou Animal Science and Veterinary Medicine AcademyShandong Binzhou Animal Science and Veterinary Medicine AcademyShandong Binzhou Animal Science and Veterinary Medicine AcademyShandong Binzhou Animal Science and Veterinary Medicine AcademyCollege of Veterinary MedicineTraditional Chinese medicine (TCM) serves as a significant adjunct to chemical treatment for chronic diseases. For instance, the administration of Baitouweng decoction (BTWD) has proven effective in the treatment of ulcerative colitis. However, the limited understanding of its pharmacokinetics (PK) has impeded its widespread use. Chinese Bama miniature pigs possess anatomical and physiological similarities to the human body, making them a valuable model for investigating PK properties. Consequently, the identification of PK properties in Bama miniature pigs can provide valuable insights for guiding the clinical application of BTWD in humans. To facilitate this research, a rapid and sensitive UPLC-MS/MS method has been developed for the simultaneous quantification of eleven active ingredients of BTWD in plasma. Chromatographic separation was conducted using an Acquity UPLC HSS T3 C18 column and a gradient mobile phase comprising acetonitrile and water (containing 0.1% acetic acid). The methodology was validated in accordance with the FDA Bioanalytical Method Validation Guidance for Industry. The lower limit of quantitation fell within the range of 0.60–2.01 ng/mL. Pharmacokinetic studies indicated that coptisine chloride, berberine, columbamine, phellodendrine, and obacunone exhibited low Cmax, while fraxetin, esculin, fraxin, and pulchinenoside B4 were rapidly absorbed and eliminated from the plasma. These findings have implications for the development of effective components in BTWD and the adjustment of clinical dosage regimens.http://dx.doi.org/10.1155/2024/5535752
spellingShingle Qianqian Xu
Huilan Gao
Fuqiang Zhu
Wenliang Xu
Yubo Wang
Jinwen Xie
Guangjun Guo
Limei Yang
Li Ma
Zhiqiang Shen
Jichang Li
Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans
International Journal of Analytical Chemistry
title Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans
title_full Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans
title_fullStr Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans
title_full_unstemmed Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans
title_short Pharmacokinetic Properties of Baitouweng Decoction in Bama Miniature Pigs: Implications for Clinical Application in Humans
title_sort pharmacokinetic properties of baitouweng decoction in bama miniature pigs implications for clinical application in humans
url http://dx.doi.org/10.1155/2024/5535752
work_keys_str_mv AT qianqianxu pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT huilangao pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT fuqiangzhu pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT wenliangxu pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT yubowang pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT jinwenxie pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT guangjunguo pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT limeiyang pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT lima pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT zhiqiangshen pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans
AT jichangli pharmacokineticpropertiesofbaitouwengdecoctioninbamaminiaturepigsimplicationsforclinicalapplicationinhumans